Carfilzomib with immunomodulatory drugs for the treatment of newly diagnosed multiple myeloma.

Landgren O, Sonneveld P, Jakubowiak A, Mohty M, Iskander KS, Mezzi K, Siegel DS

Open source

DOI
10.1038/s41375-019-0517-6
Published
2019 Sep
Container
Leukemia
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41375-019-0517-6,
  title = {Carfilzomib with immunomodulatory drugs for the treatment of newly diagnosed multiple myeloma.},
  author = {Landgren O and Sonneveld P and Jakubowiak A and Mohty M and Iskander KS and Mezzi K and Siegel DS},
  year = {2019},
  journal = {Leukemia},
  doi = {10.1038/s41375-019-0517-6},
  url = {https://doi.org/10.1038/s41375-019-0517-6}
}

RIS

TY  - JOUR
TI  - Carfilzomib with immunomodulatory drugs for the treatment of newly diagnosed multiple myeloma.
AU  - Landgren O
AU  - Sonneveld P
AU  - Jakubowiak A
AU  - Mohty M
AU  - Iskander KS
AU  - Mezzi K
AU  - Siegel DS
PY  - 2019
JO  - Leukemia
DO  - 10.1038/s41375-019-0517-6
UR  - https://doi.org/10.1038/s41375-019-0517-6
ER  - 

APA

O, L., P, S., A, J., M, M., KS, I., K, M., & DS, S. (2019). Carfilzomib with immunomodulatory drugs for the treatment of newly diagnosed multiple myeloma.. Leukemia. https://doi.org/10.1038/s41375-019-0517-6

Source records